spacer
 
spacer  
spacer
RSS
spacer spacer
spacerLogin | Subscribe | Free trial | Free reports
spacer  Agrow services
2
Subscribe to Agrow newsletter
  Issue 551
  > Contents
  > At a glance
  > Subscribe
1
Free trial
3
Click here for more details
 September 2008
  > Contents
  > Subscribe
3
spacer Agrow World Crop Protection News
spacer Agrow Magazine
spacer Agrow Intelligence
spacer Plant Biotech Projects
spacer Agrow Reports
spacer Agrow Awards
 
spacerBiotech news
Australian application for controlled release of GM torenia
By Rebecca Debens
Agrow Agricultural Biotechnology News
Thursday, 24 April 2008

Some Torenia species are grown as garden plants
Photo: Forest and Kim Starr/USGS

The Australian company, Florigene, has filed an Australian application for the limited and controlled release of  the ornamental flowering plant, torenia, genetically modified for enhanced phosphate uptake.

Three lines of around 400 plants of the modified Torenia x hybrida will be grown on a site up to 20m² in the City of Darebin, Victoria, between October 2008 and May 2009.

The plants were modified via Agrobacterium tumefaciens-mediated transformation and contain the phosphate signalling response gene, PHR1, which is thought to play a role in plant responses to phosphate deficiency.

The proposed trial involves growing the torenia hydroponically to examine both phosphate uptake and slow or repressed algal overgrowth in the surrounding water.

Yes, give me a free trial

in print and online in PDF and online
Name:
Surname:
Job Title:
Company:
Address:
City:
Country:
Post/Zip Code:
Tel:
Email:
 
Privacy Policy
A number of control measures have been outlined for the study, including locating the trial site within Florigene greenhouses, in turn surrounded by a 2.1 metre fence and lockable gates, monitoring the site on a biweekly basis, post- harvest monitoring of the trial site, destroying all plant materials not required for analysis and not using the plants in human food or animal feed.

The parent organism, Torenia x hybrida, is exotic to Australia but commercially available for home planting. The modified lines provide a sterile hybrid that does not set seed or produce viable pollen. There have been no previous releases of the GM lines in Australia, although GM torenia with altered flower colour have been previously approved for limited and controlled release.

One of the promoters used to control expression of the introduced gene in one of the three GM lines has been declared Confidential Commercial Information (CCI).

The Risk Assessment and Risk Management Plan (RARMP) is expected for release in early July 2008.

> Not a subscriber? Subscribe

 

RELATED NEWS

Arysta/Valent clothianidin deal
BASF/Bayer fungicide deal
Agrow’s Top 20: 2005 Edition - DS248 (Chapter 1)
More Biotech news

 

 
    Login
Agrow's Service Company Guide 2008
AgChem Forum
AgChem Forum
spacer.gif
Biocidal Products Directive
European Chemicals Policy

spacer

About Us  |  Privacy  |  Terms & Conditions | Advertise  |  Links  |  Contact
Informa Healthcare© 2008 Informa plc. All rights Reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36